
Hodgkin lymphoma outcomes in the novel agent era, genomic safe harbors for precision T cell engineering, and a transcriptomic atlas to map imatinib resistance in CML
Blood Podcast
00:00
Introduction
The June 1st, 2023 episode of Blood Podcast is your source for innovative ideas and cutting-edge information. For patients with relapsed or refractory Hodgkin lymphoma, survival outcomes have improved after development of several novel agents. Second on today's podcast, precision engineering of therapeutic T-cells through extragenic safe harbors.
Transcript
Play full episode